UPDATE: Vivos Therapeutics (VVOS) PT Lowered to $4 at Roth Capital
Tweet Send to a Friend
(Updated - May 20, 2022 9:19 AM EDT)
Roth Capital analyst Scott Henry lowered the price target on Vivos ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Roth Capital analyst Scott Henry lowered the price target on Vivos ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
